This unique dual formulation provides the potential benefit for smooth transition from short-term intravenous to long-term oral antiplatelet therapy. It has a plasma half-life of approximately 12 ...
Ali, H. , Ghaysaa, H. , Jaafar, W. and Malek, M. (2025) Ischemic Stroke Following Coronary Angiography: A Case Report. Case Reports in Clinical Medicine, 14, 123-129. doi: 10.4236/crcm.2025.143016 .
Intravenous. The authors have no relevant ... It is questionable whether individualized antiplatelet therapy should be based on genetic testing, platelet function testing or both.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback